Mr Diomedes Santiago, in Adjuntas, PR - Licensed Practical Nurse

Mr Diomedes Santiago, is a Licensed Practical Nurse based in Adjuntas, Puerto Rico. Mr Diomedes Santiago is licensed to practice in Puerto Rico (license number 16206) and his current practice location is Hc 1 Box 3324, Adjuntas, Puerto Rico. He can be reached at his office (for appointments etc.) via phone at (787) 450-9665.

NPI number for Mr Diomedes Santiago is 1366759169 and his current mailing address is Hc 1 Box 3324, Adjuntas, Puerto Rico. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1366759169.

Contact Information

	Mr Diomedes Santiago,
	Hc 1 Box 3324, Adjuntas, PR 00601-9522
	(787) 450-9665
	(787) 844-4130

Provider's Profile

Full Name	Mr Diomedes Santiago
Gender	Male
Speciality	Licensed Practical Nurse
Location	Hc 1 Box 3324, Adjuntas, Puerto Rico
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1366759169
Provider Enumeration Date: 09/01/2010
Last Update Date: 09/01/2010

Medical Identifiers

Medical identifiers for Mr Diomedes Santiago such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1366759169	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	16206 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Diomedes Santiago is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Diomedes Santiago, Hc 1 Box 3324, Adjuntas, PR 00601-9522 Ph: (787) 450-9665	Mr Diomedes Santiago, Hc 1 Box 3324, Adjuntas, PR 00601-9522 Ph: (787) 450-9665

News Archive

Nanovaccine boosts immunity in mice with gut microbiome-mediated metabolic syndrome

A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.

Researchers design new combination therapy for reducing NSCLC cell growth

Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.

Medicare fraud 'rampant' in Miami, spreads among different ethnic communities nationally

"Medicare fraud runs rampant in Miami-Dade" while federal experts examine how the crime spreads among different ethnic communities in different cities, The Associated Press/Miami Herald reports

Darapladib drug can protect against vision loss in diabetic patients

Researchers at Queen's University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes related blindness.

Host genetic "super-variants" may increase COVID-19 death risk

Researchers at Yale University have identified genetic variants among people of white British ancestry that may increase the risk of dying from coronavirus disease 2019 (COVID-19) – the illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Mr Diomedes Santiago, - Licensed Practical Nurse in Adjuntas, PR